- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0016823

About Zuche Pharmaceuticals Private Limited
Data last updated:
Zuche Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2010PTC206054. Its GSTIN is 07AAACZ4393G1Z3 (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.4 Lakh. It is led by directors Tarun Bharal and Umesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 602 – D/19/4 Navkar Parkview Apartment Flat No – 8 Ward No. – 3 Mehrauli, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.59 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹86.7 Lakh (net margin 5.6%) and EBITDA of ₹2.31 Cr (EBITDA margin 14.8%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 21% over five years.
The company has about 41 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.9 Cr and satisfied charges of ₹6 Cr on record. Court records list 8 cases involving the company, including 1 filed by the company and 7 filed against it.
Zuche Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0016823). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zuchepharma.com.
Company details
CIN history
Zuche Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232DL2010PTC206054. The current CIN is U52100DL2010PTC206054, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U52100DL2010PTC206054 | Current |
| U24232DL2010PTC206054 | Previous |
Recognitions & Rankings of Zuche Pharmaceuticals
Contact details
Zuche Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is zuchepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address602 – D/19/4 Navkar Parkview Apartment Flat No – 8 Ward No. – 3 Mehrauli, Delhi, India – 110030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zuche Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zuche Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zuche Pharmaceuticals Private Limited, buy the company report.
Financials of Zuche Pharmaceuticals Private Limited
FY 2025 filings availableZuche Pharmaceuticals Private Limited reported revenue of ₹15.59 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹86.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.8% | ||||
| Net Profit Margin | 5.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zuche Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zuche Pharmaceuticals Private Limited
Zuche Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Bharal | Director | 20 Jul 2010 | 16 Years 3 Months | Current |
| Umesh Kumar Singh | Director | 23 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Zuche Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hfa Formulations Private Limited | ₹15.65 Cr (FY 2024) | 42.0% | Chennai, Tamil Nadu, India | |||
| Eamon Drugs Private Limited | ₹15.64 Cr (FY 2025) | 24.0% | Indore, Madhya Pradesh, India | |||
| Zuche Pharmaceuticals Private Limitedthis company | ₹15.59 Cr (FY 2025) | ₹86.7 Lakh | 5.6% | -14.0% | 41 | Delhi, India |
| Jagannath Chemical and Pharmaceutical Works Pvt Ltd | ₹15.58 Cr (FY 2024) | 25.0% | Cuttack, Odisha, India | |||
| Bhanu Healthcare Private Limited | ₹15.58 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India | |||
| Agma Packaging Private Limited | ₹15.57 Cr (FY 2025) | -17.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Zuche Pharmaceuticals Private Limited, buy the company report.
Auditor
Zuche Pharmaceuticals Private Limited is audited by SUSHIL VERMA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUSHIL VERMA & CO | FY 2023 | 026399N |
Shareholding
The shareholding of Zuche Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zuche Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2023 | 100761866 | State Bank of India | ₹4.9 Cr | Open | |
| 24 Dec 2021 | 100523382 | Axis Bank Limited | ₹85 Lakh | Satisfied | |
| 29 Oct 2021 | 100518892 | Axis Bank Limited | ₹2.45 Cr | Satisfied | |
| 26 Feb 2020 | 100332005 | State Bank of India | ₹2.7 Cr | Satisfied |
To see the full charge records of Zuche Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Zuche Pharmaceuticals Private Limited has 8 court cases on record: 1 filed by Zuche Pharmaceuticals, 7 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 4 | 4 | 0 |
| NCLT | 2 | 2 | 0 |
| District courts | 1 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, New Delhi Bench Court-III | Company petition | Filed against the company by an individual | Disposed |
| NCLT, Principal Bench | Company petition | Filed against the company by individuals | Disposed |
| NCLAT, Court II | Tribunal matter | Filed against the company by individuals | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by individuals | Disposed |
| NCLAT, NCLAT New Delhi | Interim or miscellaneous application | Filed against the company by individuals | Disposed |
To see the full case history of Zuche Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zuche Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zuche Pharmaceuticals Private Limited has a workforce of 41 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 41 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Zuche Pharmaceuticals Private Limited, buy the company report.
GST
Zuche Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACZ4393G1Z3 | Delhi | Active | 01 Jul 2017 |
| 08AAACZ4393G1Z1 | Rajasthan | Active | 06 Dec 2019 |
To see the full GST registrations and return filing status of Zuche Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zuche Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Jagmeet Singh ceased to be Director on 23 May 2023.
2 earlier events are in the company report.
Frequently asked questions
Zuche Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 2010 (16+ years old) and is registered under CIN U52100DL2010PTC206054.
Zuche Pharmaceuticals has 2 current directors:
- Tarun Bharal - Director
- Umesh Kumar Singh - Director
The latest financial statements of Zuche Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zuche Pharmaceuticals is 07AAACZ4393G1Z3, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAACZ4393G1Z1 (Rajasthan).
The CIN (Corporate Identification Number) of Zuche Pharmaceuticals is U52100DL2010PTC206054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zuche Pharmaceuticals has 8 court cases on record: 1 filed by the company and 7 filed against it. Most are in the nclat.
Zuche Pharmaceuticals was incorporated on 20 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Zuche Pharmaceuticals by revenue are Hfa Formulations Private Limited, Eamon Drugs Private Limited, Jagannath Chemical and Pharmaceutical Works Pvt Ltd, Bhanu Healthcare Private Limited, Agma Packaging Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagmeet Singh ceased to be Director on 23 May 2023. Umesh Kumar Singh was appointed as Director on 23 Jul 2021. Jagmeet Singh was appointed as Director on 20 Jul 2010. Zuche Pharmaceuticals has 4 board changes on record in total.
Yes, Zuche Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0016823).
Zuche Pharmaceuticals can be reached through the website zuchepharma.com. Its registered office is in Delhi, India.

